1. Home
  2. HSDT vs BJDX Comparison

HSDT vs BJDX Comparison

Compare HSDT & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • BJDX
  • Stock Information
  • Founded
  • HSDT 2014
  • BJDX 2015
  • Country
  • HSDT United States
  • BJDX United States
  • Employees
  • HSDT N/A
  • BJDX N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BJDX Medical Specialities
  • Sector
  • HSDT Health Care
  • BJDX Health Care
  • Exchange
  • HSDT Nasdaq
  • BJDX Nasdaq
  • Market Cap
  • HSDT 1.8M
  • BJDX 1.8M
  • IPO Year
  • HSDT N/A
  • BJDX 2021
  • Fundamental
  • Price
  • HSDT $0.47
  • BJDX $3.64
  • Analyst Decision
  • HSDT Buy
  • BJDX
  • Analyst Count
  • HSDT 2
  • BJDX 0
  • Target Price
  • HSDT $24.00
  • BJDX N/A
  • AVG Volume (30 Days)
  • HSDT 116.7K
  • BJDX 48.0M
  • Earning Date
  • HSDT 11-12-2024
  • BJDX 11-07-2024
  • Dividend Yield
  • HSDT N/A
  • BJDX N/A
  • EPS Growth
  • HSDT N/A
  • BJDX N/A
  • EPS
  • HSDT N/A
  • BJDX N/A
  • Revenue
  • HSDT $502,000.00
  • BJDX N/A
  • Revenue This Year
  • HSDT $16.41
  • BJDX N/A
  • Revenue Next Year
  • HSDT $31.97
  • BJDX N/A
  • P/E Ratio
  • HSDT N/A
  • BJDX N/A
  • Revenue Growth
  • HSDT N/A
  • BJDX N/A
  • 52 Week Low
  • HSDT $0.37
  • BJDX $0.07
  • 52 Week High
  • HSDT $9.50
  • BJDX $31.28
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 39.76
  • BJDX 97.41
  • Support Level
  • HSDT $0.44
  • BJDX $0.07
  • Resistance Level
  • HSDT $0.58
  • BJDX $0.14
  • Average True Range (ATR)
  • HSDT 0.06
  • BJDX 0.06
  • MACD
  • HSDT 0.00
  • BJDX 0.23
  • Stochastic Oscillator
  • HSDT 4.17
  • BJDX 100.00

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Share on Social Networks: